Crescita Therapeutics Inc. (OTCMKTS:CRRTF) Stock Gains Momentum After Signing Exclusive Licensing Agreement

December 14, 2021

Crescita Therapeutics Inc. (OTCMKTS:CRRTF) is up 13% in a month. The commercial dermatology firm has signed a supply and comm3ercia agreement with a top generic pharmaceutical company, Egis Pharmaceuticals PLC. Trading Data On Monday, CRRTF stock ended flat at $0.4523 with more 30 shares, compared to its average volume of 3.4K shares. The stock has moved within a range of $0.7550 – 0.7588 after opening trade at $0.7550. Crescita Signs…